Bayer files lawsuit against Johnson and Johnson over prostate cancer drug
German drugmaker Bayer filed a lawsuit today in a New York court against Johnson and Johnson. The legal action involves the prostate cancer drug Nubeqa.
洞察:
Bayer filed a lawsuit in a New York court on Feb. 23, 2026, against Johnson & Johnson and its unit Janssen Biotech Inc. This legal action concerns Bayer's Nubeqa prostate cancer drug and establishes a formal legal dispute between the major pharmaceutical firms. The development is immediately material to company stakeholders and the legal and market context within the United States 
US.
US.
